Clinical Trial Update: A Study Of The Efficacy Of Atorvastatin For Lowering Cholesterol In High-Risk Patients With High Cholesterol [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the efficacy of atorvastatin for lowering cholesterol in high-risk patients with dyslipidemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemias

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Dyslipidemias | Phase 4 | Status: COMPLETED